Dyslipidemia in obese cats

被引:47
作者
Jordan, E. [1 ]
Kley, S. [1 ]
Le, N. -A. [2 ]
Waldron, M. [3 ]
Hoenig, M. [1 ]
机构
[1] Univ Georgia, Dept Physiol & Pharmacol, Coll Vet Med, Athens, GA 30602 USA
[2] Emory Univ, Atlanta, GA 30322 USA
[3] Nestle Purina Res, St Louis, MO USA
关键词
nuclear magnetic resonance; ultracentrifugation; diabetes;
D O I
10.1016/j.domaniend.2008.05.008
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Obesity is an important endocrine disorder in cats and is a risk factor for diabetes similar to humans. The goal of this study was to examine the effect of long-term obesity and different diets (high protein, and high carbohydrate supplemented with saturated fatty acids or n-3 polyunsaturated fatty acids) on plasma lipids in the fasted and fed states in 12 lean (LEAN) and 12 obese (OBESE) cats with ultracentrifugation, and nuclear magnetic resonance spectroscopy. OBESE had higher plasma non-esterified fatty acids and triglycerides, as well as very-low-density-lipoproteins (VLDL) consisting primarily of medium-sized particles. The concentration of low-density-lipoproteins (LDL) was comparable between the groups, although OBESE had mostly very small, whereas LEAN had mostly large particles. The concentration of high-density-lipoproteins (HDL) was lower in OBESE and consisted primarily of small particles. Plasma triglycerides, and triglycerides and cholesterol in all lipoproteins increased postprandially. Different diets had little effect on lipids. Our results show that long-term obese cats develop similar lipoprotein changes to humans, yet, hypertension and atherosclerosis have not been described in obese cats. This suggests that dyslipidemia alone is not sufficient to induce hypertension and atherosclerosis. Other anti-atherogenic factors may be present in the obese, dyslipidemic cat. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:290 / 299
页数:10
相关论文
共 71 条
[1]  
AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917
[2]   Macrophage cholesteryl ester hydrolases and hormone-sensitive lipase prefer specifically oxidized cholesteryl esters as substrates over their non-oxidized counterparts [J].
Belkner, J ;
Stender, H ;
Holzhütter, HG ;
Holm, C ;
Kühn, H .
BIOCHEMICAL JOURNAL, 2000, 352 :125-133
[3]   Free fatty acids and pathogenesis of type 2 diabetes mellitus [J].
Bergman, RN ;
Ader, M .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2000, 11 (09) :351-356
[4]   ATHEROSCLEROSIS - BASIC MECHANISMS - OXIDATION, INFLAMMATION, AND GENETICS [J].
BERLINER, JA ;
NAVAB, M ;
FOGELMAN, AM ;
FRANK, JS ;
DEMER, LL ;
EDWARDS, PA ;
WATSON, AD ;
LUSIS, AJ .
CIRCULATION, 1995, 91 (09) :2488-2496
[5]   Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women [J].
Blake, GJ ;
Otvos, JD ;
Rifai, N ;
Ridker, PM .
CIRCULATION, 2002, 106 (15) :1930-1937
[6]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]   Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation - Effects of short- and long-term simvastatin treatment [J].
Ceriello, A ;
Taboga, C ;
Tonutti, L ;
Quagliaro, L ;
Piconi, L ;
Bais, B ;
Da Ros, R ;
Motz, E .
CIRCULATION, 2002, 106 (10) :1211-1218
[8]   Glucose-stimulated insulin secretion suppresses hepatic triglyceride-rich lipoprotein and apoB production [J].
Chirieac, DV ;
Chirieac, LR ;
Corsetti, JP ;
Cianci, J ;
Sparks, CE ;
Sparks, JD .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2000, 279 (05) :E1003-E1011
[9]   High-fiber oat cereal compared with wheat cereal consumption favorably alters LDL-cholesterol subclass and particle numbers in middle-aged and older men [J].
Davy, BM ;
Davy, KP ;
Ho, RC ;
Beske, SD ;
Davrath, LR ;
Melby, CL .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2002, 76 (02) :351-358
[10]   IDENTIFICATION OF MULTIPLE DENSE LDL SUBFRACTIONS WITH ENHANCED SUSCEPTIBILITY TO INVITRO OXIDATION AMONG HYPERTRIGLYCERIDEMIC SUBJECTS - NORMALIZATION AFTER CLOFIBRATE TREATMENT [J].
DEGRAAF, J ;
HENDRIKS, JCM ;
DEMACKER, PNM ;
STALENHOEF, AFH .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (05) :712-719